Andrology

Leading Reproductive Expert Dr. Eva Schenkman Takes Helm as Director of Embryology Services at Gattaca Genomics

Retrieved on: 
Tuesday, February 27, 2024
Embryology, Education, IVF, ELD, ABB, Genomics, Entrepreneurship, Andrology, ALD, Genetic testing

Fort Lauderdale, Florida, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics proudly appoints renowned scientist, Dr. Eva Schenkman, as the Director of Embryology Services.

Key Points: 
  • Fort Lauderdale, Florida, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics proudly appoints renowned scientist, Dr. Eva Schenkman, as the Director of Embryology Services.
  • Dr. Schenkman's appointment as Director of Embryology Services signifies Gattaca Genomics' commitment to attracting top-tier talent in the field.
  • In her capacity as Director of Embryology Services, Dr. Schenkman will leverage her extensive experience in IVF laboratory management, andrology, and embryology to lead Gattaca Genomics in pioneering advancements in reproductive health.
  • Michael Carbonara, CEO of Gattaca Genomics says, "Dr. Eva Schenkman's appointment is a testament to Gattaca Genomics' commitment to excellence.

Ovation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab Director

Retrieved on: 
Tuesday, February 20, 2024
Gynaecology, OBGYN, Doctor of Philosophy, Suite, Research, Physician, Wright, IVF, ELD, ABB, Cryopreservation, Andrology, Obstetrics, University, Jan Vansina, Patient, FIRST, Knowledge, Diagnosis, Laboratory, Partnership, Medical device

Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.

Key Points: 
  • Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.
  • Dr. Warikoo comes to Ovation from the Bethesda Fertility Center Reproductive Study Lab in Cincinnati, where he has served as scientific director for more than 25 years.
  • “Ovation’s expansion in the Cincinnati area involves a close partnership with our partner physicians at the Institute for Reproductive Health, which combined with Bethesda Fertility Center effective February 1,” says Conor Beardsley, President of Ovation Fertility.
  • He is board certified by the American Board of Bioanalysis as a High Complexity Laboratory Director, Embryology Laboratory Director and Clinical Consultant.

First Fertility Appoints New Chief Scientific Officer

Retrieved on: 
Wednesday, January 3, 2024
Women, Biotechnology, Managed Care, General Health, Health, Family, Baby, Maternity, Consumer, Advancement, Pregnancy, Multimedia, Fertility, Research, ART, Reproductive medicine, College, Eastern Virginia Medical School, Laboratory, University, Society, Abstract, Andrology, Doctor of Philosophy, Patient, Publication, Risk management, Cell biology, Nursing

First Fertility , one of the largest fertility networks in the United States announced today that Alison Bartolucci, Ph.D., HCLD has been appointed as Chief Scientific Officer, furthering the company’s mission to exceed the standard of fertility care by providing compassionate, customized services with the highest quality of innovative and evidence-based reproductive technology and treatments.

Key Points: 
  • First Fertility , one of the largest fertility networks in the United States announced today that Alison Bartolucci, Ph.D., HCLD has been appointed as Chief Scientific Officer, furthering the company’s mission to exceed the standard of fertility care by providing compassionate, customized services with the highest quality of innovative and evidence-based reproductive technology and treatments.
  • In her role as the First Fertility Chief Scientific Officer, Dr. Bartolucci will lead embryology, andrology, and endocrinology lab initiatives across the First Fertility network focused on measuring and improving pregnancy outcomes and advancing scientific research, as well as compliance and risk management.
  • "I am beyond excited and honored to continue working with this organization in my new role as Chief Scientific Officer.
  • “I’m delighted that Alison has accepted the position of Chief Scientific Officer for First Fertility.

HRC Fertility Expands Services to Mission Viejo, California

Retrieved on: 
Wednesday, November 1, 2023
Other Health, General Health, Family, Consumer, Technology, Commercial Building & Real Estate, Hospitals, Construction & Property, Satellite, Baby, Maternity, Women, Health, HRC, FACOG, Fertility, News, Metropolitan area, MD, U.S. News & World Report, Dream, Patient, Andrology, Birth control, Hospital

HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, announced the launch of its new satellite office in Mission Viejo.

Key Points: 
  • HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, announced the launch of its new satellite office in Mission Viejo.
  • The growing interest and demand for reproductive/fertility services in the area and its surrounding communities made it a prominent target for HRC.
  • “I am thrilled to bring advanced fertility care to my own personal community in Mission Viejo.
  • Initially, residents will have access to a comprehensive range of services including consultations, diagnostics workups, fertility treatments and general support services.

Joe Conaghan, PhD, HCLD, Named CCRM Fertility's Director of Science and Training

Retrieved on: 
Wednesday, July 5, 2023
University, Education, Pacific Ocean, Embryology, Culture, Teaching, University of California, San Francisco, San Francisco State University, Royal Postgraduate Medical School, Research, Doctor of Philosophy, IVF, Science, Andrology, Fertility, Metabolism, Patient, UCSF, SAN, Hammersmith Hospital, Science and technology in Asia, Emil Steinberger (endocrinologist), Nursing, Birth control

SAN FRANCISCO, July 5, 2023 /PRNewswire/ -- CCRM Fertility, the global pioneer in fertility treatment, research and science, has named Joe Conaghan, PhD, HCLD, as the director of science and education. An internationally recognized embryologist, Dr. Conaghan is a board-certified high-complexity clinical laboratory director in the disciplines of embryology and andrology. In his new role at CCRM Fertility, he will be responsible for overseeing the network's West Coast lab operations; leading informative internal lab training initiatives to support embryologists' continuing education; and helping manage network research and presentations internally and for industry initiatives.

Key Points: 
  • SAN FRANCISCO, July 5, 2023 /PRNewswire/ -- CCRM Fertility , the global pioneer in fertility treatment, research and science, has named Joe Conaghan, PhD, HCLD, as the director of science and education.
  • An internationally recognized embryologist, Dr. Conaghan is a board-certified high-complexity clinical laboratory director in the disciplines of embryology and andrology.
  • "It's an honor to have a hand in elevating CCRM Fertility's cutting-edge lab operations," said Dr. Conaghan.
  • To learn more about CCRM Fertility, please visit ccrmivf.com/ .

On the Move: The Fertility Center of Las Vegas Relocates to New, State-of-the-Art Facility

Retrieved on: 
Tuesday, June 20, 2023
Reproductive medicine, Pregnancy, Partnership, Woman, Research, IVF, Andrology, Fertility, MD, Patient, Patient safety, FCLV, Female, Medical device

Las Vegas, Nevada, June 20, 2023 (GLOBE NEWSWIRE) -- The Fertility Center of Las Vegas (FCLV), a leader in fertility care and research since 1988, is pleased to announce the opening of its new, state-of-the-art clinic to best serve its ever-expanding patient base.

Key Points: 
  • Las Vegas, Nevada, June 20, 2023 (GLOBE NEWSWIRE) -- The Fertility Center of Las Vegas (FCLV), a leader in fertility care and research since 1988, is pleased to announce the opening of its new, state-of-the-art clinic to best serve its ever-expanding patient base.
  • What began as Las Vegas’ first fertility center serving local Southern Nevada patients has evolved into an enhanced new, state-of-the-art facility with a worldwide reach.
  • The new facility boasts more than twice the space as the former location and is conveniently located in Southern Las Vegas at 5365 South Durango Drive.
  • The Fertility Center of Las Vegas also partners with Ovation® Fertility Las Vegas (“Ovation”) to provide leading-edge on-site in vitro fertilization (IVF) and andrology laboratory services for reproductive medicine.

Posterity Health, National Male Fertility Company, Announces Expansion into San Francisco

Retrieved on: 
Wednesday, May 24, 2023
Other Consumer, Surgery, Parenting, Baby, Maternity, LGBTQ+, Men, Other Health, Family, Consumer, Health, San Francisco Bay Area, Male, Education, Semen analysis, Physician, AUA, NewYork-Presbyterian Hospital, American Urological Association, Infertility, Andrology, Feinberg School of Medicine, American Society for Reproductive Medicine, Fertility, Descendant, Columbia University Vagelos College of Physicians and Surgeons, MD, Patient, Surgeon, Father, University of Pennsylvania Health System, ASRM, Columbia University College of Dental Medicine, Hospital, Reproductive medicine, Society, Weill Cornell Medicine, Nursing, Birth control

Posterity Health, the only virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into San Francisco.

Key Points: 
  • Posterity Health, the only virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into San Francisco.
  • “Expanding into San Francisco helps us continue to drive our mission to bring equity to fertility by providing access to specialized male fertility care to all couples trying to conceive,” said Pam Pure, CEO and co-founder of Posterity Health.
  • Puneet Masson will spearhead our expansion into San Francisco, his passion for male fertility, his academic expertise, and surgical tenure make him the best fit to lead this region for Posterity Health.
  • “My enthusiasm for individualizing the fertility experience for male patients and their partners is what drew me to male fertility,” said Dr. Masson.

Posterity Health, National Male Fertility Company, Announces Expansion into Oregon

Retrieved on: 
Wednesday, April 19, 2023
Women, Men, Clinical Trials, Other Health, Biotechnology, Managed Care, General Health, Pharmaceutical, Consumer, Health, Male, Education, Semen analysis, Physician, AUA, NewYork-Presbyterian Hospital, American Urological Association, Infertility, Second opinion, Andrology, Feinberg School of Medicine, American Society for Reproductive Medicine, Fertility, Columbia University Vagelos College of Physicians and Surgeons, MD, Patient, Surgeon, University of Pennsylvania Health System, ASRM, Columbia University College of Dental Medicine, Hospital, Reproductive medicine, Society, Weill Cornell Medicine, Nursing, Birth control

Posterity Health, the only virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into Oregon.

Key Points: 
  • Posterity Health, the only virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into Oregon.
  • Posterity Health offers a combination of virtual visits, at-home diagnostics and in-person consultations to help assess and improve a male’s fertility status.
  • “Expanding into Oregon helps us continue to drive our mission to bring equity to fertility by providing access to specialized male fertility care to all couples trying to conceive,” said Pam Pure, CEO and co-founder of Posterity Health.
  • “My enthusiasm for individualizing the fertility experience for male patients and their partners is what drew me to Posterity Health,” said Dr. Masson.

Reproductive Medicine Associates Opens First Center in Houston and Expands Access to Outstanding Fertility Care for Texans

Retrieved on: 
Tuesday, February 28, 2023
Reproductive technology, Lone Star, IVF, Andrology, Ice cream, Patient, Fertility, Reproductive medicine, REI, Heart, Research, Journal, Ministry of Research, Innovation and Science, Evidence-Based Veterinary Medicine Association, Innovation, Suite, RMA, IUI, International Women's Day, International Women's Health Coalition, Embryology, Thomas Jefferson, Genetic testing, PGT, Yoga, Birth control, Medical device, Genetics, Infertility

HOUSTON, Feb. 28, 2023 /PRNewswire/ -- Reproductive Medicine Associates recently announced the opening of its newest fertility center in Houston, marking RMA's first expansion into the Lone Star State and adding to an extensive network of clinics around the country.

Key Points: 
  • Medical Director Nola Herlihy, M.D., has dedicated her career to building families through her practice and extensive fertility research with RMA.
  • Her research has been published in the Journal of Assisted Reproduction and Genetics, Fertility and Sterility and other peer-reviewed journals.
  • Individuals and couples worried about financing their fertility treatments should check whether their health insurance plan covers comprehensive reproductive services.
  • If fertility treatments are not covered by their insurer, many employers offer supplemental coverage through benefit providers like Progyny.

Urology Care Foundation Announces 2023 Humanitarian Recognition Award

Retrieved on: 
Thursday, January 26, 2023
United Nations Population Fund, United Nations Medal, Cheikh Anta Diop University, Genocide Convention, American Urological Association, Andrology, United Nations Assistance Mission in Afghanistan, Nature, Woman, Annual general meeting, UCF, FACS, Genocide, Research, Rwandan genocide, Medical device, Nursing, MD, Urology

BALTIMORE, Jan. 26, 2023 /PRNewswire/ -- The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce Serigne Magueye Gueye, MD, FWACS, as the recipient of its 2023 Humanitarian Recognition Award.

Key Points: 
  • BALTIMORE, Jan. 26, 2023 /PRNewswire/ -- The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce Serigne Magueye Gueye, MD, FWACS, as the recipient of its 2023 Humanitarian Recognition Award.
  • "We are honored to present Dr. Serigne Magueye Gueye with the 2023 Urology Care Foundation Humanitarian Recognition Award," said Harris M. Nagler, MD, FACS, president of the Urology Care Foundation.
  • Dr. Gueye's commitment to service, care and training is a shining example of the Urology Care Foundation's global mission."
  • The Urology Care Foundation's Humanitarian Recognition Award aims to acknowledge, on an annual basis, an individual, or individuals, for their demonstrated commitment to improving access to quality urologic health care in underserved communities and populations.